Table 2 Newer Antipsychotics and the Rabbit Syndrome.
Patient | Age | Gender | Diagnosis | Drug (mg/day) | Duration of atypical therapy | Parkinsonian symptoms | Tardive dyskinasia |
|---|---|---|---|---|---|---|---|
Patient 1 [30] | 68 | F | Schizophrenia | Risperidone (4) | 4 months | No | No |
Patient 2 [31] | 27 | M | Schizophrenia | Risperidone (4) | 7 months | No | No |
Patient 3 [32] | 38 | F | Schizophrenia | Risperidone (decresed from 2 to 1) | 8 months | No | No |
Patient 4 [33] | 38 | M | Major depression with psychotic features | Risperidone (4) | 4 months | No | No |
Patient 5 [34] | 48 | F | Schizophrenia | Clozapine (225) | 7 months | No | Yes |
Patient 6 [35] | 29 | F | Schizophreniform disorder | Aripiprazole (10) | 6 weeks | Yes | No |
Patient 7 [36] | 56 | M | Major depression with psychotic features | Risperidone (6) Biperiden (2) | 4 months | Yes | No |
Patient 8 [27] | 22 | M | Schizophrenia | Risperidone (4) Biperiden (4) | 12 months | Yes | No |
Patient 9 [37] | 42 | F | Bipolar I disorder | Risperidone (5) | 3 weeks | No | No |
Patient 10 [38] | 74 | - | Bipolar disorder | Olanzapine (20) | - | - | - |
Patient 11 (our case) | 50 | F | Bipolar I disorder | Risperidone (decresed from 4 to 1 and discontinued) | 3 months | Yes | No |